Henry O. Gosebruch, Chief Strategy Officer at AbbVie Inc. (ABBV), sold 18,800 shares at $70.00 ($1.3M) on 2017-07-31, disclosed to the SEC on 2017-08-02.
Open-market sale of $1.3M ABBV by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.00 | 5,663 | $396K | 30.1% |
| 2 | $70.00 | 100 | $7K | 0.5% |
| 3 | $70.01 | 100 | $7K | 0.5% |
| 4 | $70.01 | 1,537 | $108K | 8.2% |
| 5 | $70.02 | 600 | $42K | 3.2% |
| 6 | $70.04 | 300 |
| $21K |
| 1.6% |
| 7 | $70.05 | 100 | $7K | 0.5% |
| 8 | $70.07 | 400 | $28K | 2.1% |
| 9 | $70.08 | 100 | $7K | 0.5% |
| 10 | $70.09 | 100 | $7K | 0.5% |
| 11 | $70.10 | 400 | $28K | 2.1% |
| 12 | $70.11 | 1,000 | $70K | 5.3% |
| 13 | $70.11 | 200 | $14K | 1.1% |
| 14 | $70.12 | 700 | $49K | 3.7% |
| 15 | $70.12 | 200 | $14K | 1.1% |
| 16 | $70.13 | 800 | $56K | 4.3% |
| 17 | $70.14 | 100 | $7K | 0.5% |
| 18 | $70.15 | 100 | $7K | 0.5% |
| 19 | $70.16 | 600 | $42K | 3.2% |
| 20 | $70.17 | 400 | $28K | 2.1% |
| 21 | $70.17 | 200 | $14K | 1.1% |
| 22 | $70.18 | 200 | $14K | 1.1% |
| 23 | $70.18 | 500 | $35K | 2.7% |
| 24 | $70.19 | 300 | $21K | 1.6% |
| 25 | $70.19 | 300 | $21K | 1.6% |
| 26 | $70.19 | 1,200 | $84K | 6.4% |
| 27 | $70.20 | 500 | $35K | 2.7% |
| 28 | $70.21 | 700 | $49K | 3.7% |
| 29 | $70.22 | 400 | $28K | 2.1% |
| 30 | $70.23 | 600 | $42K | 3.2% |
| 31 | $70.25 | 200 | $14K | 1.1% |
| 32 | $70.29 | 100 | $7K | 0.5% |
| 33 | $70.34 | 100 | $7K | 0.5% |
| Total | $70.09 avg | 18,800 | $1.3M | 100% |
| Filing → |
| ABBV | SELL | 2022-05-20 | $13.0M | — | Filing → |
| ABBV | SELL | 2022-03-02 | $6.8M | — | Filing → |
| ABBV | SELL | 2022-03-01 | $2.2M | — | Filing → |